Market watchers, throughout the week, observed several Wall Street executives stepping up for new roles as part of leadership reshuffling.

Eli Lilly and Company (NYSE:LLY) was a part of 100 hedge fund portfolios at the end of Q2 2024, down from 109 in the previous ...

This roundup covers various health news highlights including the mpox outbreak in Africa and vaccine distribution issues, the ...

The conventional wisdom is that there are two important aspects of timing in investing: when to buy a stock and when to sell ...

In an average of two studies, 38% of people who took Ebglyss achieved clear or almost-clear skin at 16 weeks, compared with 12% with placebo, Eli Lilly said. "Eli Lilly Gets FDA Approval for Eczema ...

The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker ...

As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists ...

This summary covers key updates in the health sector, including vaccine distribution for mpox in Africa, FDA approvals for ...

Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...

Shares of Eli Lilly & Co. LLY shed 1.21% to $923.71 Friday, on what proved to be an all-around positive trading session for ...

The five-year-old company is developing treatments for endocrine and metabolic disorders, such as hypoparathyroidism, ...

The Indiana Budget Committee last month approved $50 million in funding for bond financing of a water pipeline from ...